170 results on '"Zigeuner, Richard"'
Search Results
2. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
3. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees
4. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
5. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
6. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
7. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
8. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
9. Erratum to “European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel” [Eur. Urol. 79(4) (2021) 480–488]
10. European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update
11. Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy
12. Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract
13. External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
14. The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?
15. Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases
16. Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma
17. A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma
18. Urothelial Carcinoma of the Upper Urinary Tract: Surgical Approach and Prognostic Factors
19. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]
20. Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases
21. Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
22. Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific Survival
23. Relationship between Age at Diagnosis and Clinicopathologic Features of Renal Cell Carcinoma
24. Serum Levels of Vascular Endothelial Growth Factor (VEGF) and Endostatin in Renal Cell Carcinoma Patients Compared to a Control Group
25. Autologous Fibrin Glue Using the Vivostat System for Hemostasis in Laparoscopic Partial Nephrectomy
26. Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer
27. Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non–muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447–61
28. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
29. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1–pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors?
30. Re: Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
31. Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus
32. Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
33. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
34. Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)
35. European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
36. Carcinoma in situ of the Upper Urinary Tract Treated with Radical Nephroureterectomy – Results from a Multicenter Study
37. Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification
38. Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
39. Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
40. The Impact of Tumor Multifocality on Outcomes in Patients Treated With Radical Nephroureterectomy
41. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer
42. Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
43. Reply from Authors re: Guido Dalbagni. Prognostication of Upper Tract Urothelial Carcinoma: What Do We Really Need? Eur Urol 2010;57:582–3
44. Editorial Comment on: Factors Predicting Health-Related Quality of Life Recovery in Patients Undergoing Surgical Treatment for Renal Tumors: Prospective Evaluation Using the RAND SF-36 Health Survey
45. Editorial Comment on: Transumbilical Single-Port Surgery: Evolution and Current Status
46. Editorial Comment on: Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney
47. Editorial Comment on: Diagnosis, Risk Factors, and Outcome of Urethral Recurrences Following Radical Cystectomy for Bladder Cancer in 729 Male Patients
48. The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?
49. Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases
50. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.